Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial

被引：0
|
作者：
Qiang Zhou
Zhiqiang Wang
Heming Wang
Zhidong Chen
Xiaoyi Li
Xiangrong Dai
Yong Zhang
Xiaohui Yu
Renpeng Zhou
Wei Hu
机构：
[1] The Second Hospital of Anhui Medical University,Department of Laboratory Medicine
[2] The Second Hospital of Anhui Medical University,Department of Clinical Pharmacology
[3] Zhujiang Hospital,Clinical Research Centre
[4] Southern Medical University,undefined
[5] The Zhaoke Pharmaceutical Co.,undefined
[6] Ltd,undefined
来源：
American Journal of Cardiovascular Drugs | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：101 / 112
页数：11
相关论文
共 50 条
  • [31] Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study
    Tzeng, Tsang-Bin
    Chang, Wei-Kuo
    Huang, Tien-Yu
    Wu, Pei-Tzu
    Huang, Wen-Chuan
    Lee, Catherine
    Wu, Hsing-Hua
    Lai, Henry
    Chang, Yi-Wei
    Lee, Ming-Chung
    Kung, Li-Pin
    Friedman, Hylar
    GASTROENTEROLOGY, 2011, 140 (05) : S572 - S572
  • [32] The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study
    Yonemori, Kan
    Shimizu, Toshio
    Kondo, Shunsuke
    Iwasa, Satoru
    Koyama, Takafumi
    Kitano, Shigehisa
    Sato, Jun
    Shimomura, Akihiko
    Shibaki, Ryota
    Suri, Ajit
    Kase, Yoichi
    Sumino, Shuuji
    Tamura, Kenji
    Yamamoto, Noboru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 693 - 699
  • [33] A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies
    Hegde, Aparna
    Jayaprakash, Priyamvada
    Couillault, Coline A.
    Piha-Paul, Sarina
    Karp, Daniel
    Rodon, Jordi
    Pant, Shubham
    Fu, Siqing
    Dumbrava, Ecaterina E.
    Yap, Timothy A.
    Subbiah, Vivek
    Bhosale, Priya
    Coarfa, Cristian
    Higgins, Jack P.
    Williams, Eric T.
    Wilson, Thomas F.
    Lim, JoAnn
    Meric-Bernstam, Funda
    Sumner, Elizabeth
    Zain, Hira
    Di Nguyen
    Nguyen, Ly M.
    Rajapakshe, Kimal
    Curran, Michael A.
    Hong, David S.
    CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3050 - 3060
  • [34] Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers
    Xiao, Y.
    Lu, Y.
    Kang, Z.
    Hou, F.
    Wang, S.
    Li, T.
    Liu, Y.
    Xia, Y.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (04) : 172 - 179
  • [35] PHASE I DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ORAL ARTESUNATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (DESPARTH TRIAL)
    Vandewynckel, Y. -P.
    Rombauts, K.
    Verhelst, X.
    Van Bortel, L.
    De Spiegeleer, B.
    Geerts, A.
    Van Vlierberghe, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S860 - S860
  • [36] Multiple-Dose Safety, Tolerability, and Pharmacokinetics of Oral Nemonoxacin (TG-873870) in Healthy Volunteers
    Chung, David T.
    Tsai, Cheng-Yuan
    Chen, Shu-Jen
    Chang, Li-Wen
    King, Chi-Hsin R.
    Hsu, Ching-Hung
    Chiu, Kit-Mui
    Tan, Hao-Chen
    Chang, Yu-Ting
    Hsu, Ming-Chu
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 411 - 417
  • [37] Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers
    Peng, Hengxin
    Zhang, Wenjun
    Lin, Yanqing
    Li, Huiming
    Qin, Suofu
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (09) : 2053 - 2070
  • [38] OPEN-LABEL, DOSE-ESCALATION, PHASE 1 STUDY OF SAFETY AND PHARMACOKINETICS OF DICHLOR-PHENAMIDE IN HEALTHY VOLUNTEERS
    Cohen, F.
    MUSCLE & NERVE, 2017, 56 : S10 - S10
  • [39] The pharmacokinetics, pharmacodynamics and tolerability of SHR6508 in chinese healthy subjects: a randomized, placebo-controlled, double-blind, single-dose and dose-escalation phase I trial
    Zhang, Sheng-ting
    Tan, Hong-yi
    Yang, Shuang
    Yang, Xiao-yan
    Cui, Chang
    Huang, Jie
    Yang, Guo-ping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [40] A Phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis
    Burton, Jodie M.
    Kimball, Samantha
    Vieth, Reinhold
    Bar-Or, Amit
    Dosch, Hans-Michael
    Thibault, Louise
    Kilborn, Sally
    D'Souza, Cheryl
    Cheung, Roy
    Ursell, Melanie
    O'Connor, Paul
    MULTIPLE SCLEROSIS, 2008, 14 : S34 - S34
12345